Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease

NCT00941642 is registered in ClinicalTrials.gov with Huntington Medical Research Institutes as lead sponsor.

NCT NCT00941642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00941642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Lead sponsor
Huntington Medical Research Institutes
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2009
Completion date
September 30, 2012
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease